The global nucleic acid testing market to reach USD 4.70 billion by 2028 at a CAGR of 7.2%, according to the latest report by Reports and Data. Major factors responsible for market revenue growth are rising prevalence of infectious diseases, cancers, etc., advancement in healthcare infrastructure, increasing awareness of nucleic acid testing methods for screening pathogenic bacteria, viruses in patient’s blood, tissue and urine. Increasing research & development activities in the field for innovating diagnosis procedures, is further expected to drive market revenue growth over the forecast period.
Nucleic acid testing (NAT) is a molecular technique for diagnosing viruses, bacteria. It is an advanced technique to detect the presence of infectious elements in blood, urine, etc. These testing methods are useful in identification of genetic disorders in early stage even if there are no visible symptoms. Nucleic acid testing methods are beneficial due to their rapid screening, accuracy, and efficiency. Increasing government spending on healthcare infrastructure is one of the key factors expected to boost market revenue growth over the forecast period. There are lucrative opportunities for the market contributors operating in the global nucleic acid testing market. The increasing number of cancer patients across the globe, and rising awareness of early detection of such disorders to avoid major complications, are some key factors expected to contribute to market growth going ahead.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Key Players covered in this report are
Applied Genetic Technologies Corporation, Abbott, Affymetrix, Becton, Dickinson and Company, Illumina, Inc., Bio-Rad, Diadexus, ELITech Group, Exact Sciences, Leica Biosystems, Perkin Elmer, and Siemens Healthineers, among others.
Product Type Outlook (Revenue, USD Billion; 2020 – 2028)
- Ligase Chain Reaction
- Polymerase Chain Reaction (PCR)
- Transcription-mediated Amplification (TMA)
- Consumables
- Whole Genome Sequencing
Technique Outlook (Revenue, USD Billion; 2020 – 2028)
- Probe Amplification Systems
- Target Amplification Systems
- Signal Amplification
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Request a sample Report of Nucleic Acid Testing Market @ https://www.reportsanddata.com/sample-enquiry-form/1429
Major Points covered in this report are as below:
• The Nucleic Acid Testing industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.
• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
• The Nucleic Acid Testing Market report provides key statistics on the market status of the Nucleic Acid Testing manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
Read More Reports:
Live Vaccines Market @ https://www.biospace.com/article/live-vaccines-market-growth-by-2026-increasing-awareness-among-the-population-rising-governmental-initiatives-increasing-healthcare-spending-capacity-of-individuals/
Injectable Sumatriptan Market @ https://www.biospace.com/article/injectable-sumatriptan-market-growth-2022-2028-rising-incidence-of-migraine-cases-all-over-the-world/
Hydroxychloroquine Market @ https://www.biospace.com/article/hydroxychloroquine-market-growth-by-2027-the-rising-geriatric-population-and-the-high-demand-for-the-drug-from-third-world-nations-for-dealing-with-malaria-are-boosting/
Dtap Vaccine Market @ https://www.biospace.com/article/dtap-vaccine-market-growth-2022-2028-growing-demand-for-dtap-vaccines-to-prevent-the-occurrence-of-diseases-such-as-diphtheria-tetanus-and-pertussis/
Plasma Expander Market @ https://www.biospace.com/article/plasma-expander-market-growth-by-2027-increase-in-the-number-of-accidents-and-surgeries-changes-in-lifestyle-are-factors-estimated-to-fuel-the-growth/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
0 Comments
Post a Comment